Feature
Matthew Wood Discusses the Future of Rare Disease Innovation on In Vivo Podcast
January 20, 2026
Matthew Wood, Director and Chief Scientific Officer of the Oxford-Harrington Rare Disease Center (OHC), recently joined the In Vivo podcast to discuss a pivotal moment for rare disease research and development, highlighting both unprecedented scientific opportunity and persistent structural challenges.